If you fill prescriptions to treat Attention Deficit Hyperactivity Disorder (ADHD), such as Ritalin or Adderall, you know the generic versions of these medications have been in limited supply since 2011. But drug makers have told the Food and Drug Administration that they will release enough medication--particularly the short-acting versions of these drugs--in April, which should end the shortage, according to FDA spokesperson, Shelly Burgess.
More
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.